Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
about
d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology.Modern Clinical Research on LSD.Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies.Beyond serotonin: newer antidepressants in the future.Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking.Behavioral Changes Over Time Following Ayahuasca Exposure in ZebrafishEffects of the Natural β-Carboline Alkaloid Harmine, a Main Constituent of Ayahuasca, in Memory and in the Hippocampus: A Systematic Literature Review of Preclinical Studies.Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalised women in a Canadian setting.Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.Lessons to be learned from early psychedelic therapy in Denmark.Unifying Theories of Psychedelic Drug Effects.Reaction of N,N-Dimethyltryptamine with Dichloromethane Under Common Experimental Conditions.Four Weekly Ayahuasca Sessions Lead to Increases in "Acceptance" Capacities: A Comparison Study With a Standard 8-Week Mindfulness Training Program.Acute Intoxication following Dimethyltryptamine Ingestion.Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and DevelopmentMore Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant DepressionA Single Dose of 5-MeO-DMT Stimulates Cell Proliferation, Neuronal Survivability, Morphological and Functional Changes in Adult Mice Ventral Dentate Gyrus
P2860
Q28067851-DCECB518-776A-435C-BD83-9929B0A47D4EQ30401421-EDDDC853-34D7-4629-85C2-9CB8CDA96B52Q33693380-30A7F9C2-05CA-4AE7-9AFF-48A6AEF391CBQ34557706-D2DADBCF-99E6-4658-BB92-3DEB9F503B71Q37184458-DC89EA01-F453-4D7F-A87D-28E8C650BEADQ38626654-2929B4CA-34C6-4D14-A354-28C4F985328FQ39029520-9FC670FB-76DD-4EFF-B6F7-2D6C2C973D4EQ41932270-2DB6F337-2841-4373-AD30-C9E1A7F60FEFQ47550103-F410FBAA-B87A-4AC3-BFC6-1EF136852479Q48187582-E03DF3C6-0723-44F2-82D9-D5F98E5AD827Q52641641-971AB5D3-2343-4945-9059-B1AEE4D0624EQ54918894-4A3BA508-AD33-43E1-84DC-DDD9B319EADDQ55001918-83F11C11-5079-4B14-A548-0134661DC8DFQ55283483-8F2C4563-ED32-4980-AC8B-CD4479B1AE6AQ57309250-AD4DD94D-E263-4E9D-B016-C10E306ECAA6Q58122738-1ABBBB7E-99E6-491D-B9C8-BAAF96949A9CQ58764693-9C76D284-8F20-46E8-91D1-A741F9748B6A
P2860
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Antidepressive, anxiolytic, an ...... published in the last 25 years
@ast
Antidepressive, anxiolytic, an ...... published in the last 25 years
@en
Antidepressive, anxiolytic, an ...... published in the last 25 years
@nl
type
label
Antidepressive, anxiolytic, an ...... published in the last 25 years
@ast
Antidepressive, anxiolytic, an ...... published in the last 25 years
@en
Antidepressive, anxiolytic, an ...... published in the last 25 years
@nl
prefLabel
Antidepressive, anxiolytic, an ...... published in the last 25 years
@ast
Antidepressive, anxiolytic, an ...... published in the last 25 years
@en
Antidepressive, anxiolytic, an ...... published in the last 25 years
@nl
P2093
P2860
P3181
P356
P1476
Antidepressive, anxiolytic, an ...... published in the last 25 years
@en
P2093
Antônio W Zuardi
Flávia L Osório
Jaime E C Hallak
José Alexandre S Crippa
P2860
P304
P3181
P356
10.1177/2045125316638008
P407
P577
2016-03-18T00:00:00Z